Fennell DA - Search Results

1

Caspase regulation in non-small cell lung cancer and its potential for therapeutic exploitation.

Fennell DA. Fennell DA. Clin Cancer Res. 2005 Mar 15;11(6):2097-105. doi: 10.1158/1078-0432.CCR-04-1482. Clin Cancer Res. 2005. PMID: 15788654 Review.

2

Bcl-2 as a target for overcoming chemoresistance in small-cell lung cancer.

Fennell DA. Fennell DA. Clin Lung Cancer. 2003 Mar;4(5):307-13. doi: 10.3816/clc.2003.n.012. Clin Lung Cancer. 2003. PMID: 14609451

3

In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion.

Szlosarek PW, Klabatsa A, Pallaska A, Sheaff M, Smith P, Crook T, Grimshaw MJ, Steele JP, Rudd RM, Balkwill FR, Fennell DA. Szlosarek PW, et al. Among authors: fennell da. Clin Cancer Res. 2006 Dec 1;12(23):7126-31. doi: 10.1158/1078-0432.CCR-06-1101. Clin Cancer Res. 2006. PMID: 17145837

4

Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer.

Fennell DA, Steele JP, Shamash J, Slater SE, Sheaff MT, Wells P, Rudd RM, Stebbing J. Fennell DA, et al. Int J Cancer. 2007 Dec 1;121(11):2575-7. doi: 10.1002/ijc.22984. Int J Cancer. 2007. PMID: 17680556 Clinical Trial.

5

Src and ADAM-17-mediated shedding of transforming growth factor-alpha is a mechanism of acute resistance to TRAIL.

Van Schaeybroeck S, Kelly DM, Kyula J, Stokesberry S, Fennell DA, Johnston PG, Longley DB. Van Schaeybroeck S, et al. Among authors: fennell da. Cancer Res. 2008 Oct 15;68(20):8312-21. doi: 10.1158/0008-5472.CAN-07-6736. Cancer Res. 2008. PMID: 18922903 Free PMC article.

6

Procaspase 8 overexpression in non-small-cell lung cancer promotes apoptosis induced by FLIP silencing.

Wilson TR, Redmond KM, McLaughlin KM, Crawford N, Gately K, O'Byrne K, Le-Clorrenec C, Holohan C, Fennell DA, Johnston PG, Longley DB. Wilson TR, et al. Among authors: fennell da. Cell Death Differ. 2009 Oct;16(10):1352-61. doi: 10.1038/cdd.2009.76. Epub 2009 Jun 19. Cell Death Differ. 2009. PMID: 19543235

7

New advances in the second-line treatment of small cell lung cancer.

Hurwitz JL, McCoy F, Scullin P, Fennell DA. Hurwitz JL, et al. Among authors: fennell da. Oncologist. 2009 Oct;14(10):986-94. doi: 10.1634/theoncologist.2009-0026. Epub 2009 Oct 9. Oncologist. 2009. PMID: 19819917 Free article. Review.

8

Voltage dependent anion channel-1 regulates death receptor mediated apoptosis by enabling cleavage of caspase-8.

Chacko AD, Liberante F, Paul I, Longley DB, Fennell DA. Chacko AD, et al. Among authors: fennell da. BMC Cancer. 2010 Jul 20;10:380. doi: 10.1186/1471-2407-10-380. BMC Cancer. 2010. PMID: 20646307 Free PMC article.

9

Gene expression meta-analysis identifies VDAC1 as a predictor of poor outcome in early stage non-small cell lung cancer.

Grills C, Jithesh PV, Blayney J, Zhang SD, Fennell DA. Grills C, et al. Among authors: fennell da. PLoS One. 2011 Jan 31;6(1):e14635. doi: 10.1371/journal.pone.0014635. PLoS One. 2011. PMID: 21297950 Free PMC article.

10

Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer.

Pallis AG, Fennell DA, Szutowicz E, Leighl NB, Greillier L, Dziadziuszko R. Pallis AG, et al. Among authors: fennell da. Br J Cancer. 2011 Jun 28;105(1):1-8. doi: 10.1038/bjc.2011.207. Epub 2011 Jun 7. Br J Cancer. 2011. PMID: 21654681 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters